Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins

Blood

Volumn 103, Issue 6, 2004, Pages 2088-2095

  García, Angel ^a   Prabhakar, Sripadi ^b   Hughan, Sascha ^b   Anderson, Tom W ^b   Brock, Chris J ^b   Pearce, Andrew C ^b   Dwek, Raymond A ^b   Watson, Steve P ^b   Hebestreit, Holger F ^b   Zitzmann, Nicole ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COLLAGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN VI; PROTEIN TYROSINE KINASE; RGS PROTEIN; RGS10 PROTEIN; RGS18 PROTEIN; SERINE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TYROSINE KINASE DOK2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; THROMBOCYTE ACTIVATION; THROMBOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 12144289394     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2392     Document Type: Article

References (51)

1. Flores NA, Botchway ANS, Stavrou BM, Turner MA, Sheridan DJ. Platelets, plaques and heart attacks. Biologist. 1999;46:219-224.
2. Vu T-K H, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
3. Kahn ML, Zheng Y-W, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature. 1998;394:690-694.
4. Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A. 1998;95:6642-6646.
5. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103:879-887.
6. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci U S A. 1999;96:11189-11193.
7. Fusté B, Díaz-Ricart M, Jensen MK, Ordinas A, Escolar G, White JB. TRAP induces more intense tyrosine phosphorylation than thrombin with differential ultrastructural features. Am J Pathol. 2002;160:2245-2252.
8. Hollenberg MD, Compton SJ. International union of pharmacology, XXVIII: proteinase-activated receptors. Pharmacol Rev. 2002;54:203-217.
9. Ramars AS, Mukhopadhyay S, Dash D. Regulation of post-aggregation events induced by protease-activated receptor 1 ligation in human platelets: evidence of differential signaling pathways. Arch Biochem Biophys. 2002;398:253-260.
10. Chung AW, Jurasz P, Hollenberg MD, Radomski MW. Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol. 2002;135:1123-1132.
11. Hebestreit HF, Dwek RA. Proteomics: a new concept for pharmaceutical research? Eur Pharm Rev. 2001;6:23-33.
12. Hebestreit HF. Proteomics: an holistic analysis of nature's proteins. Curr Opin Pharmacol. 2001;5:513-520.
13. Görg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000;21:1037-1053.
14. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics. 2002;2:288-305.
15. García A, Prabhakar S, Brock CJ, et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics. In press.
16. Francischetti IM, Saliou B, Leduc M, et al. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrifucus venom, specifically binds to platelets. Toxicon. 1997;35:1217-1228.
17. Emambokus N R, Frampton J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. Immunity. 2003;19:33-45.
18. Suzuki-Inoue K, Inoue O, Frampton J, Watson SP. Murine GPVI stimulates weak integrin activation in PLCγ2-/- platelets: involvement of PLCγ1 and PI3-kinase. Blood. 2003;102:1367-1373.
19. Hassner A, Birnbaum D, Loew LM. Charge-shift probes of membrane potential: synthesis. J Org Chem. 1984;49:2546-2551.
20. Shevchenko A, Jensen ON, Podtelejnikov AV, et al. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci U S A. 1996;93:14440-14445.
21. Tyers M, Haslam RJ, Rachubinski RA, Harley CB. Molecular analysis of pleckstrin: the major protein kinase C substrate of platelets. J Cell Biochem. 1989;40:133-145.
22. Tyers M, Rachubinski RA, Stewart MI, et al. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 1988;333:470-473.
23. dok-2 defines a new family of rasGAP-binding proteins. J Biol Chem. 1998;273:4827-4830.
24. Hoving S, Gerrits B, Voshol H, Müller D, Roberts RC, van Oostrum J. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow rage immobilized pH gradients. Proteomics. 2002;2:127-134.
25. Westbrook JA, Yan JX, Wait R, Welson SY, Dunn MJ. Zooming-in on the proteome: very narrow-range immobilized pH gradients reveal more protein species and isoforms. Electrophoresis. 2001;22:2865-2871.
26. Toker A, Bachelot C, Chen C-S, et al. Phosphorylation of the platelet p47 phosphoprotein is mediated by the lipid products of phosphoinositide 3-kinase. J Biol Chem. 1995;270:29525-29531.
27. Butt E, Immler D, Meyer HE, Kotlyarov A, Laass K, Gaestel M. Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants. J Biol Chem. 2001;276:7108-7113.
28. Bauer M, Wilde JI, Maschberger P, et al. Dichotomous regulation of myosin phosphorylation and shape change by rho-kinase and calcium in intact human platelets. Blood. 1999;94:1665-1672.
29. Maguire PB, Wynne KJ, Harney DF, O'Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics. 2002;2:642-648.
30. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999;294:1351-1362.
31. Abrams CS, Kazanietz MG. Platelet signaling: protein kinase C. In: Gresele C, Page C, Fuster V, Vermylen J, eds. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology and therapeutics. Cambridge, United Kingdom: Cambridge University Press; 2002:272-280.
32. Wheeler-Jones CPD, Learmonth MP, Martin H, Aitken A. Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation. Biochem J. 1996;315:41-47.
33. Autieri MV, Carbone CJ. 14-3-3Gamma interacts with and is phosphorylated by multi protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA Cell Biol. 1999;18:555-564.
34. Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP-kinase signaling by RKIP. Nature. 1999;401:173-177.
35. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem. 2003;278:13061-13068.
36. Pasquet JM, Noury M, Nurden AT. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway. Thromb Haemost. 2002;088:115-122.
37. Landry Y, Gies JP. Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery. Mini Rev Med Chem. 2002;2:361-372.
38. Gagnon AW, Murray DL, Leadley RJ. Cloning and characterization of a novel regulator of G protein signaling in human platelets. Cell Signal. 2002;14:595-606.
39. Haller C, Fillatreau S, Hoffmann R, Agenes F. Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling 10 gene (mRGS10). Gene. 2002;297:39-49.
40. Hunt TW, Fields TA, Casey PJ, Peralta EG. RGS10 is a selective activator of G alpha i GTPase activity. Nature. 1996;383:175-177.
41. Benzing T, Yaffe MB, Arnould T, et al. 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem. 2000;275:28167-28172.
42. Cunningham ML, Waldo GL, Hollinger S, Hepler JR, Harden TK. Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling. J Biol Chem. 2001;276:5438-5444.
43. Burgon PG, Lee WL, Nixon AB, Peralta EG, Casey PJ. Phosphorylation and nuclear translocation of a regulator of protein signaling (RGS10). J Biol Chem. 2001;276:32828-32834.
44. Chen C, Wang H, Fong CW, Lin SC. Multiple phosphorylation sites in RGS16 differentially modulate its GAP activity. FEBS Lett. 2001;504:16-22.
45. Hollinger S, Ramineni S, Hepler JR. Phosphorylation of RGS14 by protein kinase A potentiates its activity towar Gαi. Biochemistry. 2003;42:811-819.
46. Derrien A, Zheng B, Osterhout JL, et al. Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability. J Biol Chem. 2003;278:16107-16116.
47. Abramson J, Rozenblum G, Pecht I. Dok protein family members are involved in signaling mediated by the type 1 FCε receptor. Eur J Immnunol. 2003;33:85-91.
48. Jones N, Dumont DJ. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. Curr Biol. 1999;9:1057-1060.
49. Master Z, Tran J, Bishnoi A, et al. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoeskeletal reorganization. J Biol Chem. 2003;278:30170-30179.
50. Calderwood DA, Fujioka Y, de Pereda JM, et al. Integrin β cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A. 2003;100:2272-2277.
51. 3 signaling and platelet function. Nature. 1999;401:808-811.